Defendant entity record
L'Oréal USA lawsuits
Cosmetics conglomerate; lead defendant (with other manufacturers) in the chemical hair relaxer litigation — the fourth-largest active MDL at 12,381 pending cases (Oct. 1, 2026).
Claims in these lawsuits are allegations until a court or settlement resolves them.
Key facts
| Cases we track | 1 |
|---|
The entity record
- Fact 1
- 12,381 — pending cases (Oct. 1, 2026), 4th-largest active MDL
- Source: https://www.jpml.uscourts.gov/
- Fact 2
- MDL-3060 — N.D. Ill., Judge Mary M. Rowland
- Source: https://www.jpml.uscourts.gov/
The hair relaxer litigation (MDL-3060, Judge Mary M. Rowland, N.D. Illinois) consolidates claims that chemical straightening products caused uterine and other hormone-driven cancers, with filings accelerating after federal researchers published findings linking frequent relaxer use to elevated uterine-cancer risk.
As of October 1, 2026 the docket held 12,381 pending cases — the fourth-largest active MDL in the country — against L'Oréal and other manufacturers. No test-trial verdicts have been returned; the first federal test trial is set for September 7, 2027. Allegations remain allegations until adjudicated.
The claimant population and marketing history give this docket an unusually pointed accountability dimension — products marketed heavily to Black women over decades — which is central to plaintiffs' failure-to-warn theories.
Public-record events
Jul 1, 2026 · Other
Docket lists 12,381 pending cases (Oct. 1, 2026) — fourth-largest active MDL.
View source ↗Feb 6, 2023 · Other
JPML centralizes the hair relaxer litigation as MDL-3060 in the Northern District of Illinois.
View source ↗
Find the case for what you took or used
Open a case and answer a few questions in its free check. Only if you choose to can a law firm review your information.